Fundz

Pliant Therapeutics Appoints Minnie Kuo as Chief Operating Officer

PUBLIC · PLRXDec 16, 2025

Position

Chief Operating Officer

Company

Pliant Therapeutics

Minnie Kuo
mkuo@pliantrx.com
San FranciscoBiotechnologyHealth CareMedicalTherapeutics

Description

On December 10, 2025, Pliant Therapeutics, Inc appointed Minnie Kuo as Chief Operating Officer, effective immediately. Ms Kuo brings extensive experience to her new role, having previously served as Chief Development Officer. She joined the Company in September 2023.

Quick answer

Pliant Therapeutics Appoints Minnie Kuo as Chief Operating Officer (December 16, 2025). Pliant Therapeutics is based in San Francisco, California, United States.

Who is the new Chief Operating Officer at Pliant Therapeutics?
Pliant Therapeutics named Minnie Kuo Chief Operating Officer, announced December 16, 2025.
What did Pliant Therapeutics announce on December 16, 2025?
On December 10, 2025, Pliant Therapeutics, Inc appointed Minnie Kuo as Chief Operating Officer, effective immediately. Ms Kuo brings extensive experience to her new role, having previously served as Chief Development Officer.
What does Pliant Therapeutics do?
Pliant Therapeutics is a late-stage biopharmaceutical company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases.
Where is Pliant Therapeutics based?
Pliant Therapeutics is based in San Francisco, California, United States.
Which similar companies made leadership changes around the same time?
Novocure (December 1, 2025), Damora Therapeutics, Inc. (January 6, 2026), NuCana (January 6, 2026) and Archeus Technologies (January 7, 2026) also announced leadership changes within 45 days of Pliant Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Pliant Therapeutics, and when

A new leader at Pliant Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Pliant Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Pliant Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Pliant Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Pliant Therapeutics

Location

260 LITTLEFIELD AVENUE

San Francisco, California, United States

About

Pliant Therapeutics is a late-stage biopharmaceutical company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases. At Pliant, we share a commitment and a clear passion to drive innovative science towards addressing areas of unmet medical need. Together we believe we have the power to make a difference in the lives of patients and those impacted by fibrotic diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Pliant Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Delphine
Likely contact at this company
••••••••@••••••••

See Delphine's verified email →

David
Likely contact at this company
••••••••@••••••••

See David's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Pliant Therapeutics's next move

Learn about Strategic plan

Pliant Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.